ReviewTherapeutic advances in urology

Abiraterone acetate in combination with prednisone in the treatment of metastatic hormone-sensitive prostate cancer: clinical evidence and experience.

Karin Purshouse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.